Filter
614
Text search:
FDA
Featured
Recommendations
81
New Publications
121
Language
Document type
No document type
303
Guidelines
160
Studies & Reports
75
Manuals
24
Fact sheets
24
Strategic & Response Plan
13
Training Material
7
Resource Platforms
3
Brochures
2
Situation Updates
2
Infographics
1
Countries / Regions
India
29
Ghana
17
Latin America and the Carribbean
17
Russia
17
Philippines
12
Myanmar / Burma
12
South Africa
9
Middle East and North Africa
9
USA
8
Kenya
8
Brazil
8
Global
8
Nigeria
7
Congo, Democratic Republic of
7
Germany
7
Syria
7
Argentina
7
West and Central Africa
7
Senegal
6
Uganda
6
Ukraine
6
Colombia
6
Ecuador
6
Yemen
6
Western and Central Europe
6
South Sudan
5
Angola
5
Paraguay
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Mali
4
Ethiopia
4
Indonesia
4
Mozambique
4
Sudan
4
Peru
4
Eastern Europe and Central Asia
4
Guinea
3
Sierra Leone
3
Nepal
3
Tanzania
3
Thailand
3
Bangladesh
3
Bolivia
3
East and Southern Africa
3
South–East Asia Region
3
Africa
3
Venezuela
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Iraq
2
Jordan
2
Rwanda
2
Namibia
2
El Salvador
2
Chile
2
Asia
2
Albania
2
Tajikistan
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Somalia
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
Mauritania
1
Singapore
1
Malawi
1
Benin
1
Dominican Republic
1
Cuba
1
Honduras
1
Botswana
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Armenia
1
Congo-Brazzaville
1
Qatar
1
Moldova
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
190
Clinical Guidelines
80
Pharmacy & Technologies
22
Women & Child Health
17
Public Health
11
Key Resources
8
Capacity Building
2
Toolboxes
COVID-19
136
Mental Health
69
TB
59
HIV
48
Pharmacy
35
AMR
30
Ebola
28
Rapid Response
17
Specific Hazards
13
NTDs
10
Zika
8
Refugee
7
NCDs
7
Planetary Health
6
Cholera
3
Conflict
3
Natural Hazards
3
Caregiver
3
Global Health Education
2
Disability
1
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij
...
Guidelines for the care of children and adolescents diagnosed with COVID - 19.
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
Estas directrices sustituyen a los anteriores documentos de política de la OMS sobre el manejo de la ILTB en las personas con la infección por el VIH, los contactos del hogar de personas con TB y otros grupos de riesgo. Las Directrices unificadas de la OMS sobre la tuberculosis: Tratamiento preven
...
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac
...
Updated Guidelines
Technical guidelines for testing for COVID-19 in the clinical laboratories of the National Integrated Health System.
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio
...
